![biotech_employer_img](/_next/image?url=%2Fimages%2Fworking_process_shap.png&w=3840&q=75)
![edit_profile](https://production-biostaffic-media.s3.amazonaws.com/company-logos/RefleXion.png)
RefleXion
United States
Member Since:Jan 17, 2024
Ownership:N/A
Number of Offices:N/A
Total Employees:N/A
Established In:N/A
RefleXion is a privately held therapeutic oncology company located in Hayward, Calif., transforming radiopharmaceuticals from diagnosing cancer to actively controlling delivery of external-beam radiotherapy by leveraging individual tumor biology. Designated an FDA Breakthrough Device, RefleXion’s SCINTIX™ biology-guided radiotherapy automates targeting and motion management to overcome long-standing barriers preventing definitive radiotherapy for metastatic disease. In strategic collaborations with radiopharmaceutical companies, RefleXion is co-developing and co-commercializing disease-specific radiopharmaceuticals for difficult to treat late-stage cancers. RefleXion’s vision is to extend the established safety, efficacy and cost-effectiveness of external-beam radiotherapy to patients with solid tumor malignancies of any stage.
CONNECT
No record available!
No record available!
No record available!
No record available!
No record available!
No record available!